看看查看全文
来源:格隆汇 格隆汇6月14日丨Agile Therapeutics(AGRX.US)盘前涨35.65%,报4.87美元。Agile Therapeutics宣布与VitaCare处方服务公司达成新协议,以扩大Twirla的使用范围,推动公司2023年实现净收入2500万至30... 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, item 1.01 Accession Number: 0001558370-20-005100 Act: 34 Size: 39 KB 网页链接
$Agile Therapeutics(AGRX)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-20-004292 Act: 34 Size: 1 MB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001558370-20-004156 Act: 34 Size: 88 KB 网页链接
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-008589 Size: 9 KB 网页链接
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-034104 Size: 4 KB 网页链接
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-029907 Size: 5 KB 网页链接
$Agile Therapeutics(AGRX)$ 内部交易: 2020-02-27,CEO,ALTOMARI ALFRED ,买入,10000普通股, $2.71
$Agile Therapeutics(AGRX)$ 内部交易: 2020-02-27,CEO,ALTOMARI ALFRED ,期权,16541普通股, $0.71
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-026463 Size: 7 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-20-025410 Act: 34 Size: 5 MB 网页链接